Picture of UCB SA logo

UCB UCB SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: UCB's Rystiggo Receives Approval In Japan For Two New Administration Methods

May 9 (Reuters) - Ucb SA UCB.BR:

RYSTIGGO (ROZANOLIXIZUMAB) RECEIVES APPROVAL IN JAPAN FOR TWO NEW ADMINISTRATION METHODS AS UCB BEGINS ONWARD PROGRAM FOR PATIENT SUPPORT

COMPLEMENTING THIS APPROVAL, UCB JAPAN WILL LAUNCH A HOME DELIVERY SERVICE FOR RYSTIGGO

Source text: here

Further company coverage: UCB.BR

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on UCB SA

See all news